{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:20:27Z","timestamp":1768634427962,"version":"3.49.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe a patient conceiving with <jats:italic>in vitro<\/jats:italic> fertilization and embryo transfer(IVF-ET) after conservative treatment of early stage endometrial cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient<\/jats:title><jats:p>A 31-year-old multiparous woman diagnosed with highly-differentiated (G1) endometrial adenocarcinoma (grade IA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention(s)<\/jats:title><jats:p>After four courses of conservative treatment each followed by hysteroscopic biopsy and endometrial curettage,assisted reproductive technology was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measure(s)<\/jats:title><jats:p>Successful pregnancy and delivery without residual endometrial cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results(s)<\/jats:title><jats:p>A healthy normal female infant with a birth weight of 3,690 g was born by cesarean section at 38 + 2 weeks\u2019 gestation. No residual malignant cells was detected on a biopsy during cesarean section.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion(s)<\/jats:title><jats:p>Conservative fertility-sparing treatment are crucial for young patients with early stage endometrial cancer. Assisted reproductive technologies may be considered to assist such patients to conceive as soon as possible.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1461216","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:24:49Z","timestamp":1733937889000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: A successful live birth after in vitro fertilization and embryo transfer in a patient with endometrial cancer who was treated conservatively"],"prefix":"10.3389","volume":"14","author":[{"given":"Yifan","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","author":"Rodolakis","year":"2023","journal-title":"Int J Gynecological Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Center"},{"key":"B3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"B4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3892\/mco.2023.2651","article-title":"Conservative treatment of endometrial cancer in women of reproductive age (Review)","volume":"19","author":"Bourou","year":"2023","journal-title":"Mol Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58091256","article-title":"Conservative management of atypical endometrial hyperplasia and early endometrial cancer in childbearing age women","volume":"58","author":"Uccella","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1342239","article-title":"A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer","volume":"34","author":"Kim","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.05.031","article-title":"A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively","volume":"81","author":"Yarali","year":"2004","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2019-000756","article-title":"Endometrial cancer during pregnancy: management strategies","volume":"29","author":"Eriksson","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.975","article-title":"Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate","volume":"5","author":"Zhao","year":"2013","journal-title":"Oncol Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v145.7","article-title":"Risk factors for endometrial cancer: An umbrella review of the literature","volume":"145","author":"Raglan","year":"2019","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejogrb.2019.04.009","article-title":"The risk of Malignancy in uterine polyps: A systematic review and meta-analysis","volume":"237","author":"Uglietti","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00175-w","article-title":"Expression of stromal progesterone receptor and differential methylation patterns in the endometrium may correlate with response to progesterone therapy in endometrial complex atypical hyperplasia","volume":"27","author":"Neal","year":"2020","journal-title":"Reprod Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.827724","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e57","article-title":"Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment","volume":"32","author":"Zhou","year":"2021","journal-title":"J Gynecologic Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092535","article-title":"Tamoxifen and endometrial cancer: A janus-headed drug","volume":"12","author":"Emons","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S216146","article-title":"Dual targeting of estrogen receptor alpha and estrogen-related receptor alpha: a novel endocrine therapy for endometrial cancer","volume":"12","author":"Mao","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020292","article-title":"The role of gonadotropin-releasing hormone (GnRH) in endometrial cancer","volume":"10","author":"Emons","year":"2021","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1341162","article-title":"Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers","volume":"14","author":"Desaulniers","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6236","article-title":"Synergistic effect of metformin and medroxyprogesterone 17\u2212acetate on the development of endometrial cancer","volume":"39","author":"Mu","year":"2018","journal-title":"Oncol Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.12.006","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Xie","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ygyno.2017.05.002","article-title":"Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer","volume":"146","author":"Park","year":"2017","journal-title":"Gynecologic Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bmj.l4693","article-title":"Pregnancy duration and endometrial cancer risk: nationwide cohort study","author":"Husby","year":"2019","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00808-y","article-title":"Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia","volume":"19","author":"Fan","year":"2021","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1461216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:24:56Z","timestamp":1733937896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1461216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":25,"alternative-id":["10.3389\/fonc.2024.1461216"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1461216","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"article-number":"1461216"}}